Remember…..George Livery the newly appointed Executive Chairman was instrumental in negotiating the A$1.67 billion sale of Swisse to Biostime (now H&H Group) and now one of his remuneration incentives with Bod includes a “takeover incentive” which states if Bod becomes subject to a takeover or change of control transaction (which is ultimately approved by the Board and shareholders), then George will benefit from an additional (significant) number of options each with an exercise price of $0.50.
Do your own research...
Takeover incentive!
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
